LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Clinical trial NCT03412890 · COMPLETED
Trial details
- NCT number
- NCT03412890
- Sponsor
- Myovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-19
- Primary completion
- 2020-01-21
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.